Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease
- 1 March 2015
- journal article
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 9 (2) , 168-174
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effect of dietary resveratrol on the metabolic profile of nutrients in obese OLETF ratsLipids in Health and Disease, 2013
- Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 proteinThe Journal of Nutritional Biochemistry, 2012
- Effects of Green Tea Polyphenol (−)-Epigallocatechin-3-gallate on Newly Developed High-Fat/Western-Style Diet-Induced Obesity and Metabolic Syndrome in MiceJournal of Agricultural and Food Chemistry, 2011
- Screening of soy protein-derived hypotriglyceridemic di-peptides in vitro and in vivoLipids in Health and Disease, 2011
- Effects of Citrus Auraptene (7-Geranyloxycoumarin) on Hepatic Lipid Metabolism in Vitro and in VivoJournal of Agricultural and Food Chemistry, 2010
- Causes and control of excess body fatNature, 2009
- Fatty acid metabolism: target for metabolic syndromeJournal of Lipid Research, 2009
- Fatty LiverArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARα, promotes energy consumption and reduces visceral fat deposition in ratsBiochimica et Biophysica Acta (BBA) - General Subjects, 2006
- C-Reactive Protein, Inflammation, and Innate ImmunityImmunologic Research, 2001